In fact, MYCN-amplification has been shown to promote both glycolysis and OXPHOS in neuroblastoma [45], and its inhibition triggers a mitochondrial respiratory chain defect and accumulation of lipid droplets, signifying a reduction in fatty acid oxidation [46]. The gene discussed is MYCN; the disease is neuroblastoma.